Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Vibrio cholerae infection	6/50	0.0014820217457412615	0.45646269768830855	0	0	4.8	31.26887077908564	KCNQ1;ADCY3;PLCG1;PRKACA;ATP6V1D;ATP6V0A1
Dilated cardiomyopathy (DCM)	7/91	0.007793448162696157	1.0	0	0	3.076923076923077	14.93683654587159	LMNA;CACNA2D3;ITGB8;ADCY3;ITGAV;PRKACA;SLC8A1
Chemokine signaling pathway	11/190	0.008476604918739727	0.8702647716572787	0	0	2.31578947368421	11.047346947308263	NCF1;CCL7;GNG4;WAS;ADCY3;ARRB1;CXCR6;PRKACA;RASGRP2;PLCB2;MAPK3
Adrenergic signaling in cardiomyocytes	9/145	0.010798033066635283	0.8314485461309168	0	0	2.482758620689655	11.242902500436786	CREB3;PPP2CB;KCNQ1;CACNA2D3;ADCY3;PRKACA;PLCB2;SLC8A1;MAPK3
Ribosome biogenesis in eukaryotes	7/101	0.013413164283940805	0.8262509198907535	0	0	2.7722772277227725	11.952724956502475	RBM28;UTP6;WDR3;CSNK2A2;RPP40;REXO2;RPP38
Apelin signaling pathway	8/137	0.021940705845488007	1.0	0	0	2.335766423357664	8.921253496118961	CDH1;GNG4;SPP1;ADCY3;PRKACA;PLCB2;SLC8A1;MAPK3
Cholinergic synapse	7/112	0.022431444848228562	0.9869835733220568	0	0	2.5	9.493228791607109	CREB3;GNG4;KCNQ1;ADCY3;PRKACA;PLCB2;MAPK3
Hepatocellular carcinoma	9/168	0.0256658294226503	0.9881344327720366	0	0	2.142857142857143	7.848417356197167	WNT10B;NQO1;SMARCD3;TXNRD1;ACTL6A;PLCG1;BAK1;MET;MAPK3
Taurine and hypotaurine metabolism	2/11	0.02954667996708659	1.0	0	0	7.2727272727272725	25.612973778194785	GGT7;CSAD
Adherens junction	5/72	0.034121963499969904	1.0	0	0	2.7777777777777777	9.38281669756106	CDH1;CSNK2A2;WAS;MET;MAPK3
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	5/72	0.034121963499969904	0.9554149779991573	0	0	2.7777777777777777	9.38281669756106	LMNA;CACNA2D3;ITGB8;ITGAV;SLC8A1
Melanoma	5/72	0.034121963499969904	0.8757970631658942	0	0	2.7777777777777777	9.38281669756106	CDH1;FGF18;BAK1;MET;MAPK3
Hematopoietic cell lineage	6/97	0.034816933065960357	0.8248934911012147	0	0	2.4742268041237114	8.307591162530308	CD4;CSF3R;CR1;CD1E;CD59;CD1D
Platelet activation	7/124	0.03629100572845635	0.7984021260260398	0	0	2.258064516129032	7.488160455296562	P2RX1;BTK;ADCY3;PRKACA;RASGRP2;PLCB2;MAPK3
Oocyte meiosis	7/125	0.03765326408972758	0.7731470226424063	0	0	2.2399999999999998	7.345711817659683	PPP2CB;CCNB1;CDC26;ADCY3;PRKACA;YWHAG;MAPK3
Thyroid hormone synthesis	5/74	0.037751290429200716	0.7267123407621138	0	0	2.7027027027027026	8.856042217071249	CREB3;ADCY3;PRKACA;PLCB2;ASGR2
Phosphatidylinositol signaling system	6/99	0.03790132072194009	0.6866827519033852	0	0	2.4242424242424243	7.93398623019715	DGKG;PPIP5K1;INPPL1;PLCG1;DGKZ;PLCB2
Ribosome	8/153	0.03870333178459044	0.6622570105363254	0	0	2.0915032679738563	6.801212214435727	MRPS11;MRPL17;MRPL14;MRPL13;MRPL35;MRPL32;MRPS5;MRPS18C
Melanogenesis	6/101	0.04115481492961408	0.6671412104379545	0	0	2.376237623762376	7.581182612623305	WNT10B;CREB3;ADCY3;PRKACA;PLCB2;MAPK3
Galactose metabolism	3/31	0.04160691113161275	0.6407464314268363	0	0	3.8709677419354835	12.307699325969082	HK3;GAA;GLA
RNA polymerase	3/31	0.04160691113161275	0.610234696596987	0	0	3.8709677419354835	12.307699325969082	POLR2J3;POLR3C;POLR2D
Relaxin signaling pathway	7/130	0.0449669377075316	0.6295371279054425	0	0	2.1538461538461537	6.680859827081968	CREB3;GNG4;ADCY3;ARRB1;PRKACA;PLCB2;MAPK3
Parathyroid hormone synthesis, secretion and action	6/106	0.0500409395743879	0.6701134516918031	0	0	2.2641509433962264	6.780936944361775	CREB3;ADCY3;ARRB1;PRKACA;PLCB2;MAPK3
Prion diseases	3/35	0.056354567885378765	0.7232169545290276	0	0	3.4285714285714284	9.860886785287258	PRNP;PRKACA;MAPK3
Hypertrophic cardiomyopathy (HCM)	5/85	0.0618191895456952	0.7616124152029649	0	0	2.352941176470588	6.5495092994558615	LMNA;CACNA2D3;ITGB8;ITGAV;SLC8A1
Primary immunodeficiency	3/37	0.06453588403923348	0.7645020109263043	0	0	3.2432432432432434	8.888217950878486	CD4;BTK;ADA
Thyroid cancer	3/37	0.06453588403923348	0.7361871216327375	0	0	3.2432432432432434	8.888217950878486	CDH1;BAK1;MAPK3
Glutamatergic synapse	6/114	0.06653353765237376	0.7318689141761113	0	0	2.1052631578947367	5.705366595473973	HOMER1;GNG4;ADCY3;PRKACA;PLCB2;MAPK3
Thyroid hormone signaling pathway	6/116	0.07109725651068904	0.7551018967342147	0	0	2.068965517241379	5.469737646755102	THRA;ITGAV;PLCG1;PRKACA;PLCB2;MAPK3
Human papillomavirus infection	13/330	0.07234393578298902	0.7427310740386872	0	0	1.5757575757575755	4.138449383476485	WNT10B;LAMA5;PPP2CB;CREB3;TRAF3;SPP1;ITGB8;ITGAV;BAK1;PRKACA;ATP6V1D;ATP6V0A1;MAPK3
Rap1 signaling pathway	9/206	0.07471621197069322	0.7423417189346294	0	0	1.7475728155339805	4.533305561948185	CDH1;FGF18;ADCY3;PLCG1;RASGRP2;SIPA1L3;PLCB2;MET;MAPK3
Pathways in cancer	19/530	0.07488030086529318	0.7207228958284468	0	0	1.4339622641509433	3.716635784773042	WNT10B;NQO1;LAMA5;CSF3R;TXNRD1;ADCY3;RASGRP2;CDH1;TRAF3;GNG4;FGF18;ITGAV;PLCG1;BAK1;PRKACA;PLCB2;MET;PPARD;MAPK3
TGF-beta signaling pathway	5/90	0.07506739964971518	0.7006290633973417	0	0	2.222222222222222	5.754153126676802	TGIF1;PPP2CB;TGIF2;ID3;MAPK3
Ferroptosis	3/40	0.07776165816733924	0.7044291386923672	0	0	2.9999999999999996	7.6623203846665575	PRNP;SLC7A11;GCLM
Fc gamma R-mediated phagocytosis	5/91	0.07788799770256499	0.6854143797825719	0	0	2.1978021978021975	5.609853650799394	NCF1;INPPL1;WAS;PLCG1;MAPK3
Cortisol synthesis and secretion	4/65	0.079512678248973	0.6802751361301023	0	0	2.4615384615384617	6.232218572816643	CREB3;ADCY3;PRKACA;PLCB2
Pantothenate and CoA biosynthesis	2/19	0.08063617099611983	0.6712416396433759	0	0	4.2105263157894735	10.601296667256518	BCAT1;AASDHPPT
One carbon pool by folate	2/20	0.08816218183787267	0.7145776843701258	0	0	4.0	9.714308741076266	AMT;GART
NF-kappa B signaling pathway	5/95	0.08973008930567587	0.7086376283627736	0	0	2.1052631578947367	5.075682362950664	TNFSF14;TRAF3;CSNK2A2;BTK;PLCG1
Epithelial cell signaling in Helicobacter pylori infection	4/68	0.09037481756509516	0.6958860952512327	0	0	2.352941176470588	5.655975569761716	PLCG1;MET;ATP6V1D;ATP6V0A1
Amoebiasis	5/96	0.09282858900482821	0.697346473499685	0	0	2.0833333333333335	4.952084615544676	LAMA5;ARG2;CD1D;PRKACA;PLCB2
Cushing syndrome	7/155	0.09461742127485875	0.6938610893489642	0	0	1.8064516129032255	4.25945693896194	KMT2D;WNT10B;CREB3;ADCY3;PRKACA;PLCB2;MAPK3
Circadian entrainment	5/97	0.09598139817691856	0.6874946660114166	0	0	2.0618556701030926	4.832166753155399	GNG4;ADCY3;PRKACA;PLCB2;MAPK3
Vasopressin-regulated water reabsorption	3/44	0.09705771960273352	0.6794040372191346	0	0	2.727272727272727	6.361225718177528	CREB3;ADCY3;PRKACA
Osteoclast differentiation	6/127	0.09931318145472103	0.6797435530678684	0	0	1.889763779527559	4.364365933204153	NCF1;BTK;LILRA1;FCGR2C;SIRPB1;MAPK3
Calcium signaling pathway	8/188	0.10030202986048892	0.6715875042832736	0	0	1.7021276595744679	3.9141605894941525	P2RX1;ADCY3;VDAC1;PLCG1;PRKACA;PLCB2;SLC8A1;TPCN1
Choline metabolism in cancer	5/99	0.10244796021859995	0.6713611010069954	0	0	2.02020202020202	4.602828918210063	DGKG;WAS;PLCG1;DGKZ;MAPK3
Progesterone-mediated oocyte maturation	5/99	0.10244796021859995	0.657374411402683	0	0	2.02020202020202	4.602828918210063	CCNB1;CDC26;ADCY3;PRKACA;MAPK3
Mismatch repair	2/23	0.11187435504137663	0.7032102316886532	0	0	3.4782608695652173	7.618709103989623	PCNA;RPA3
Leishmaniasis	4/74	0.11407613801901988	0.7027090101971625	0	0	2.1621621621621623	4.693814434937615	CR1;NCF1;FCGR2C;MAPK3
Endocrine and other factor-regulated calcium reabsorption	3/48	0.11807273003133849	0.7130666833265147	0	0	2.5	5.341136220470389	PRKACA;PLCB2;SLC8A1
Gastric acid secretion	4/75	0.11826909586753341	0.7005169524461595	0	0	2.1333333333333333	4.5542245917778965	KCNQ1;ADCY3;PRKACA;PLCB2
Neomycin, kanamycin and gentamicin biosynthesis	1/5	0.11891526936765551	0.691054772929017	0	0	8.0	17.03475249279432	HK3
Malaria	3/49	0.12357090514220292	0.7048118293296018	0	0	2.4489795918367343	5.120669772142008	CR1;LRP1;MET
Ovarian steroidogenesis	3/49	0.12357090514220292	0.6919970687963363	0	0	2.4489795918367343	5.120669772142008	CYP1B1;ADCY3;PRKACA
Cholesterol metabolism	3/50	0.12916025190606503	0.7103813854833577	0	0	2.4	4.912083318606716	LRP1;OSBPL5;VDAC1
Complement and coagulation cascades	4/79	0.13568722199833994	0.7331870943068193	0	0	2.0253164556962022	4.045372921890401	CR1;SERPINB2;CD59;TFPI
Collecting duct acid secretion	2/27	0.1456305058632748	0.7733482035498042	0	0	2.962962962962963	5.708689324070283	ATP6V1D;ATP6V0A1
ECM-receptor interaction	4/82	0.14939050479141397	0.7798690758602628	0	0	1.951219512195122	3.709642075934028	LAMA5;SPP1;ITGB8;ITGAV
Cell adhesion molecules (CAMs)	6/145	0.15619002119741085	0.801775442146709	0	0	1.6551724137931034	3.0731287090708483	NTNG2;CD4;CDH1;ITGB8;ITGAV;CD58
Phospholipase D signaling pathway	6/148	0.16683342934024545	0.8423720694556656	0	0	1.6216216216216217	2.903934151506698	DGKG;ADCY3;PLCG1;DGKZ;PLCB2;MAPK3
Insulin secretion	4/86	0.1684397588656009	0.8367652537194368	0	0	1.8604651162790697	3.3138178739793065	CREB3;ADCY3;PRKACA;PLCB2
Gastric cancer	6/149	0.17044793665898042	0.8333010236661265	0	0	1.610738255033557	2.8499200843945487	WNT10B;CDH1;FGF18;BAK1;MET;MAPK3
Endometrial cancer	3/58	0.17675775807092875	0.8506467107163446	0	0	2.068965517241379	3.5854656874425306	CDH1;BAK1;MAPK3
Gap junction	4/88	0.1782707420189226	0.8447290544896641	0	0	1.8181818181818181	3.1353670212637206	ADCY3;PRKACA;PLCB2;MAPK3
PI3K-Akt signaling pathway	12/354	0.1782875494868804	0.8320085642721085	0	0	1.3559322033898304	2.338111980426809	PPP2CB;CREB3;LAMA5;CSF3R;GNG4;FGF18;SPP1;ITGB8;ITGAV;MET;YWHAG;MAPK3
Phagosome	6/152	0.1814837820990341	0.8342836550224254	0	0	1.5789473684210524	2.694614185414532	NCF1;CTSL;ITGAV;ATP6V1D;FCGR2C;ATP6V0A1
Sulfur relay system	1/8	0.18337711757031785	0.8305904737008515	0	0	5.0	8.481052474133024	MOCS3
Human T-cell leukemia virus 1 infection	8/219	0.1839997192748942	0.8213320802415567	0	0	1.461187214611872	2.473528470581535	CREB3;CD4;MMP7;CDC26;ADCY3;VDAC1;PRKACA;MAPK3
Long-term depression	3/60	0.18933665205922548	0.8330812690605921	0	0	2.0	3.3284572412017854	PPP2CB;PLCB2;MAPK3
Morphine addiction	4/91	0.193365469000841	0.8388248514402681	0	0	1.7582417582417582	2.889095839916935	GNG4;ADCY3;ARRB1;PRKACA
Lysosome	5/123	0.19494638291830557	0.833937304706085	0	0	1.6260162601626016	2.6585865327153817	CTSL;GAA;CTSF;GLA;ATP6V0A1
Glycerolipid metabolism	3/61	0.19571013951815233	0.8257359311176837	0	0	1.9672131147540983	3.2087618250165857	DGKG;DGKZ;GLA
Human cytomegalovirus infection	8/225	0.20294459162437736	0.8446883002744354	0	0	1.422222222222222	2.268191694023834	CREB3;GNG4;ADCY3;ITGAV;BAK1;PRKACA;PLCB2;MAPK3
GnRH signaling pathway	4/93	0.2036425912242253	0.8362922412941519	0	0	1.7204301075268817	2.737873248162342	ADCY3;PRKACA;PLCB2;MAPK3
Small cell lung cancer	4/93	0.2036425912242253	0.8252883960139656	0	0	1.7204301075268817	2.737873248162342	LAMA5;TRAF3;ITGAV;BAK1
Wnt signaling pathway	6/158	0.20436847453628693	0.8174738981451477	0	0	1.5189873417721518	2.4118946836174078	WNT10B;MMP7;CSNK2A2;PRKACA;PLCB2;PPARD
MAPK signaling pathway	10/295	0.2057791446090391	0.812563801789539	0	0	1.3559322033898304	2.143663456089143	MAP4K2;DUSP10;FGF18;CACNA2D3;ARRB1;PRKACA;RASGRP2;MAPK8IP3;MET;MAPK3
SNARE interactions in vesicular transport	2/34	0.20850978329059616	0.8129242183987799	0	0	2.352941176470588	3.6888689802047985	VTI1B;BET1
Hippo signaling pathway	6/160	0.21221988601068234	0.8170465611411271	0	0	1.4999999999999998	2.3251985154973505	WNT10B;MOB1A;PPP2CB;CDH1;RASSF4;YWHAG
Autophagy	5/128	0.2170847599208247	0.8254580994520248	0	0	1.5625	2.3866678171750295	PPP2CB;ATG16L2;CTSL;PRKACA;MAPK3
Central carbon metabolism in cancer	3/65	0.2216910070831208	0.8326930509951366	0	0	1.8461538461538463	2.7811767260910543	HK3;MET;MAPK3
Synthesis and degradation of ketone bodies	1/10	0.22371474296156477	0.8301703714718306	0	0	4.0	5.989534030397172	HMGCL
Glycerophospholipid metabolism	4/97	0.22465400248636988	0.823731342450023	0	0	1.6494845360824741	2.4630001271451514	DGKG;PNPLA7;PLD4;DGKZ
DNA replication	2/36	0.22698728149273847	0.8224950905854523	0	0	2.222222222222222	3.2952473149705526	PCNA;RPA3
Starch and sucrose metabolism	2/36	0.22698728149273847	0.8129311941832958	0	0	2.222222222222222	3.2952473149705526	HK3;GAA
Aminoacyl-tRNA biosynthesis	3/66	0.22829261173331122	0.8082083265960903	0	0	1.8181818181818181	2.685685614666917	SARS2;NARS2;TARS
Non-small cell lung cancer	3/66	0.22829261173331122	0.7990241410665893	0	0	1.8181818181818181	2.685685614666917	PLCG1;BAK1;MAPK3
Aldosterone synthesis and secretion	4/98	0.2299929805556841	0.7959307641702327	0	0	1.6326530612244896	2.3995207997514747	CREB3;ADCY3;PRKACA;PLCB2
Dopaminergic synapse	5/131	0.23072798787052096	0.7896024473791161	0	0	1.5267175572519083	2.2389554259440514	CREB3;PPP2CB;GNG4;PRKACA;PLCB2
Long-term potentiation	3/67	0.23493078009641188	0.7951503326340095	0	0	1.7910447761194028	2.594264527179215	PRKACA;PLCB2;MAPK3
FoxO signaling pathway	5/132	0.23533006344596197	0.7878441254495248	0	0	1.5151515151515151	2.1920700378167894	CCNB1;HOMER1;AGAP2;S1PR1;MAPK3
cGMP-PKG signaling pathway	6/166	0.2363733785248731	0.7828279632866766	0	0	1.4457831325301203	2.0853146194472134	CREB3;ADCY3;VDAC1;PLCB2;SLC8A1;MAPK3
Proteoglycans in cancer	7/201	0.23889613956034234	0.7827660743041005	0	0	1.3930348258706466	1.9944447140428132	WNT10B;CTSL;ITGAV;PLCG1;PRKACA;MET;MAPK3
Inflammatory mediator regulation of TRP channels	4/100	0.24076340791661854	0.7805803119823002	0	0	1.5999999999999999	2.2783048601180695	ADCY3;PLCG1;PRKACA;PLCB2
Fc epsilon RI signaling pathway	3/68	0.2416025942539262	0.7751416565646799	0	0	1.7647058823529411	2.5066960150114252	BTK;PLCG1;MAPK3
Ubiquinone and other terpenoid-quinone biosynthesis	1/11	0.2431315551769016	0.7720053504586153	0	0	3.6363636363636362	5.142373101111616	NQO1
Tight junction	6/170	0.25292341771831894	0.7949021699718595	0	0	1.4117647058823528	1.940708516953507	PPP2CB;PCNA;WAS;CD1E;CD1D;PRKACA
Estrogen signaling pathway	5/137	0.2587049099112584	0.804859719723915	0	0	1.45985401459854	1.97382074569392	CREB3;ADCY3;PRKACA;PLCB2;MAPK3
B cell receptor signaling pathway	3/71	0.26179144524840503	0.8063176513650875	0	0	1.6901408450704225	2.2651387651401085	INPPL1;BTK;MAPK3
Glycine, serine and threonine metabolism	2/40	0.2642113633345378	0.8057138604657192	0	0	2.0	2.662011754937148	AMT;BPGM
Bile secretion	3/72	0.2685696227705788	0.8109749393464535	0	0	1.6666666666666665	2.1910751599377134	EPHX1;ADCY3;PRKACA
Bladder cancer	2/41	0.2735343283108339	0.8179473118421053	0	0	1.951219512195122	2.529420780778097	CDH1;MAPK3
Fatty acid biosynthesis	1/13	0.28052310882224873	0.830779976127429	0	0	3.076923076923077	3.911074378522308	OXSM
Bacterial invasion of epithelial cells	3/74	0.28218271785894006	0.8277359723862242	0	0	1.6216216216216217	2.051676457611424	CDH1;WAS;MET
Inositol phosphate metabolism	3/74	0.28218271785894006	0.8199271424580522	0	0	1.6216216216216217	2.051676457611424	INPPL1;PLCG1;PLCB2
Insulin resistance	4/108	0.2848542905983054	0.819954406582038	0	0	1.4814814814814814	1.8604110970526841	CREB3;SLC27A3;SLC27A2;PPARGC1B
NOD-like receptor signaling pathway	6/178	0.28690868886067566	0.8182210756397047	0	0	1.348314606741573	1.6834938487080762	TRAF3;CARD9;VDAC1;TP53BP1;PLCB2;MAPK3
Apoptosis	5/143	0.2874305990194729	0.81218921557796	0	0	1.3986013986013985	1.7437396400000038	CTSL;LMNA;CTSF;BAK1;MAPK3
Glioma	3/75	0.2890124517878938	0.8092348650061026	0	0	1.5999999999999999	1.986056809642578	PLCG1;BAK1;MAPK3
Axon guidance	6/181	0.2999028666848604	0.8321629093597929	0	0	1.3259668508287292	1.5968574158723403	EFNB2;NTNG2;ROBO3;PLCG1;MET;MAPK3
Carbohydrate digestion and absorption	2/44	0.30144914903771564	0.828985159853718	0	0	1.8181818181818181	2.180279885359369	HK3;PLCB2
Glycosphingolipid biosynthesis	2/45	0.31071849114810757	0.8469141174656384	0	0	1.7777777777777777	2.077987466447498	FUT7;GLA
Retrograde endocannabinoid signaling	5/148	0.3117935434195852	0.8423895734494057	0	0	1.3513513513513513	1.5748838243444059	GNG4;ADCY3;PRKACA;PLCB2;MAPK3
Serotonergic synapse	4/113	0.31299039884400204	0.8382699377735011	0	0	1.415929203539823	1.6447189572138212	GNG4;PRKACA;PLCB2;MAPK3
Type II diabetes mellitus	2/46	0.3199619156443703	0.8495540518833281	0	0	1.7391304347826086	1.981831832838938	HK3;MAPK3
Cysteine and methionine metabolism	2/47	0.32917493125894143	0.8665459728867859	0	0	1.7021276595744679	1.891346320966911	GCLM;BCAT1
Hedgehog signaling pathway	2/47	0.32917493125894143	0.8592023629470674	0	0	1.7021276595744679	1.891346320966911	ARRB1;PRKACA
Nucleotide excision repair	2/47	0.32917493125894143	0.8519821750231424	0	0	1.7021276595744679	1.891346320966911	PCNA;RPA3
Sphingolipid metabolism	2/47	0.32917493125894143	0.8448823235646163	0	0	1.7021276595744679	1.891346320966911	SMPD3;GLA
Oxytocin signaling pathway	5/153	0.33642013035703416	0.8563421499997234	0	0	1.3071895424836601	1.4240451139027008	CACNA2D3;ADCY3;PRKACA;PLCB2;MAPK3
Chemical carcinogenesis	3/82	0.33702536869684624	0.8508509308084315	0	0	1.4634146341463412	1.5916054733134235	SULT1A1;EPHX1;CYP1B1
Valine, leucine and isoleucine degradation	2/48	0.3383532866029959	0.8472586363717295	0	0	1.6666666666666665	1.8061078378867632	HMGCL;BCAT1
Peroxisome	3/83	0.34388610305783524	0.8541687075952681	0	0	1.4457831325301203	1.5432936465472034	HMGCL;PEX3;SLC27A2
Hepatitis C	5/155	0.3463196387966962	0.8533315899950594	0	0	1.2903225806451613	1.3682491855800498	PPP2CB;TRAF3;BAK1;YWHAG;MAPK3
Sphingolipid signaling pathway	4/119	0.34704829641584545	0.8483402801276222	0	0	1.3445378151260503	1.4229127071807743	PPP2CB;S1PR1;PLCB2;MAPK3
Arginine and proline metabolism	2/49	0.3474929610282407	0.8427388346196703	0	0	1.6326530612244896	1.7257320330061812	ARG2;CARNS1
Cocaine addiction	2/49	0.3474929610282407	0.8361549374742041	0	0	1.6326530612244896	1.7257320330061812	CREB3;PRKACA
Selenocompound metabolism	1/17	0.3498657220916832	0.8353383132111506	0	0	2.352941176470588	2.4710725865370216	TXNRD1
Huntington disease	6/193	0.3527901274453759	0.835841225024429	0	0	1.2435233160621761	1.2956044833233389	POLR2J3;CREB3;POLR2D;VDAC1;PLCB2;DNAL1
N-Glycan biosynthesis	2/50	0.3565901556321914	0.8383951750741598	0	0	1.5999999999999999	1.6498690882006875	GANAB;MGAT2
Thermogenesis	7/231	0.35690264551808415	0.8327728395421963	0	0	1.2121212121212122	1.2488390739665034	CREB3;SMARCD3;ACTL6A;NDUFAF3;ADCY3;PRKACA;COA6
Ras signaling pathway	7/232	0.3609757651052984	0.8359438770859541	0	0	1.206896551724138	1.229760549831967	GNG4;FGF18;PLCG1;PRKACA;RASGRP2;MET;MAPK3
Cell cycle	4/124	0.37548462272034455	0.8630542074467621	0	0	1.2903225806451613	1.263919690443347	CCNB1;PCNA;CDC26;YWHAG
Focal adhesion	6/199	0.3795402740781548	0.8659141067857162	0	0	1.2060301507537687	1.168395453737611	LAMA5;SPP1;ITGB8;ITGAV;MET;MAPK3
GABAergic synapse	3/89	0.38485531890079877	0.871584104569456	0	0	1.348314606741573	1.2874891825427501	GNG4;ADCY3;PRKACA
Viral carcinogenesis	6/201	0.38846981218186155	0.8733481908906084	0	0	1.1940298507462686	1.1290027650329573	CREB3;TRAF3;BAK1;PRKACA;YWHAG;MAPK3
Salivary secretion	3/90	0.39163344766088204	0.8740804484025483	0	0	1.3333333333333333	1.2499052788690577	ADCY3;PRKACA;PLCB2
RNA transport	5/165	0.39594842156275617	0.8773533369879777	0	0	1.2121212121212122	1.122995545199561	EIF2B2;CLNS1A;RPP40;ELAC1;RPP38
Rheumatoid arthritis	3/91	0.39839258143942596	0.8764636791667371	0	0	1.3186813186813187	1.2136053287868656	CTSL;ATP6V1D;ATP6V0A1
Pathogenic Escherichia coli infection	2/55	0.40132045183103177	0.8766432564819701	0	0	1.4545454545454544	1.3279927840918175	CDH1;WAS
Regulation of lipolysis in adipocytes	2/55	0.40132045183103177	0.8704697124222379	0	0	1.4545454545454544	1.3279927840918175	ADCY3;PRKACA
Purine metabolism	4/129	0.40381118360940044	0.8697471646971702	0	0	1.2403100775193798	1.1247229489297248	PNP;ADCY3;GART;ADA
Th1 and Th2 cell differentiation	3/92	0.40513108190704056	0.8665303696345034	0	0	1.3043478260869563	1.1785364415810688	CD4;PLCG1;MAPK3
Glutathione metabolism	2/56	0.41009437639646396	0.8710970202076613	0	0	1.4285714285714284	1.273382799199648	GGT7;GCLM
IL-17 signaling pathway	3/93	0.41184736294433893	0.8688286834716191	0	0	1.2903225806451613	1.1446483568607568	CCL7;TRAF3;MAPK3
Arginine biosynthesis	1/21	0.41253720829731133	0.8643636745276999	0	0	1.9047619047619047	1.6865311911285241	ARG2
Vascular smooth muscle contraction	4/132	0.42069740654476995	0.8755054136201968	0	0	1.2121212121212122	1.0495047915438824	ADCY3;PRKACA;PLCB2;MAPK3
Terpenoid backbone biosynthesis	1/22	0.42723918724304594	0.8831521454420009	0	0	1.8181818181818181	1.5462023001914358	ICMT
VEGF signaling pathway	2/59	0.43602582146324703	0.8953063534045339	0	0	1.3559322033898304	1.1254966967419524	PLCG1;MAPK3
Human immunodeficiency virus 1 infection	6/212	0.43743860898225356	0.8922588845465834	0	0	1.1320754716981132	0.936021402290767	CCNB1;CD4;GNG4;PLCG1;BAK1;MAPK3
Histidine metabolism	1/23	0.4415739476417069	0.8947682623266165	0	0	1.7391304347826086	1.4215822280628116	CARNS1
Pancreatic secretion	3/98	0.4450435426086273	0.8959046478657333	0	0	1.2244897959183672	0.9913263098498469	KCNQ1;ADCY3;PLCB2
Insulin signaling pathway	4/137	0.44857167121284724	0.8971433424256944	0	0	1.167883211678832	0.9362765643386131	HK3;INPPL1;PRKACA;MAPK3
Vitamin digestion and absorption	1/24	0.455550643812525	0.9052232148016627	0	0	1.6666666666666665	1.310413975931712	BTD
AGE-RAGE signaling pathway in diabetic complications	3/100	0.4581166423834544	0.9044867041929741	0	0	1.2	0.9367577395196145	PLCG1;PLCB2;MAPK3
HIF-1 signaling pathway	3/100	0.4581166423834544	0.8987256423828277	0	0	1.2	0.9367577395196145	HK3;PLCG1;MAPK3
Fluid shear stress and atherosclerosis	4/139	0.4596056772594075	0.895940180986693	0	0	1.1510791366906474	0.8948332437112545	NQO1;NCF1;CTSL;ITGAV
Signaling pathways regulating pluripotency of stem cells	4/139	0.4596056772594075	0.8903053370811163	0	0	1.1510791366906474	0.8948332437112545	WNT10B;ID3;SKIL;MAPK3
T cell receptor signaling pathway	3/101	0.4646041358021239	0.8943629614190884	0	0	1.188118811881188	0.9107757110849387	CD4;PLCG1;MAPK3
Tuberculosis	5/179	0.4646752739691283	0.8889440023757237	0	0	1.1173184357541899	0.8563312322847955	CR1;CARD9;FCGR2C;ATP6V0A1;MAPK3
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/25	0.4691782022031496	0.8920178165343832	0	0	1.5999999999999999	1.2108361930392557	PIGV
Alcoholism	5/180	0.4695071787707449	0.887166939026929	0	0	1.111111111111111	0.8400796557824288	CREB3;GNG4;PKIA;PRKACA;MAPK3
Basal cell carcinoma	2/63	0.46961389196045544	0.881957797096465	0	0	1.2698412698412698	0.9598024487193709	WNT10B;BAK1
Longevity regulating pathway	3/102	0.4710573837797299	0.8793071163888292	0	0	1.176470588235294	0.8856180687760349	CREB3;ADCY3;PRKACA
Chagas disease (American trypanosomiasis)	3/103	0.47747528768906305	0.8859180036640447	0	0	1.1650485436893203	0.8612538337064508	PPP2CB;PLCB2;MAPK3
Glucagon signaling pathway	3/103	0.47747528768906305	0.8806131054385116	0	0	1.1650485436893203	0.8612538337064508	CREB3;PRKACA;PLCB2
Toll-like receptor signaling pathway	3/104	0.4838567938447761	0.8870707887154229	0	0	1.1538461538461537	0.8376534190762757	TRAF3;SPP1;MAPK3
Mitophagy	2/65	0.48595425402499	0.8856444392881474	0	0	1.2307692307692308	0.8881732763477085	FUNDC1;CSNK2A2
Shigellosis	2/65	0.48595425402499	0.8804347661158641	0	0	1.2307692307692308	0.8881732763477085	WAS;MAPK3
Acute myeloid leukemia	2/66	0.49400617659427287	0.8897889028715558	0	0	1.2121212121212122	0.8547966771455834	PPARD;MAPK3
Kaposi sarcoma-associated herpesvirus infection	5/186	0.4981933861356625	0.8921137379638607	0	0	1.075268817204301	0.7492117760889532	TRAF3;GNG4;PLCG1;BAK1;MAPK3
Th17 cell differentiation	3/107	0.5027730441661714	0.8951103907698312	0	0	1.1214953271028036	0.7711585964262758	CD4;PLCG1;MAPK3
Breast cancer	4/147	0.5029167460190818	0.8902204469763058	0	0	1.0884353741496597	0.748114979541874	WNT10B;FGF18;BAK1;MAPK3
Butanoate metabolism	1/28	0.5080520173426427	0.8941715505230512	0	0	1.4285714285714284	0.9673877718600257	HMGCL
Amphetamine addiction	2/68	0.5098678748711668	0.892268781024542	0	0	1.176470588235294	0.7924748890682	CREB3;PRKACA
Glycolysis / Gluconeogenesis	2/68	0.5098678748711668	0.8872277144650813	0	0	1.176470588235294	0.7924748890682	HK3;BPGM
Renal cell carcinoma	2/69	0.5176757123539347	0.8957534798034376	0	0	1.1594202898550725	0.7633695892092621	MET;MAPK3
Renin secretion	2/69	0.5176757123539347	0.8907492704190608	0	0	1.1594202898550725	0.7633695892092621	PRKACA;PLCB2
TNF signaling pathway	3/110	0.5213279209858358	0.8920499981313189	0	0	1.0909090909090908	0.7105920309159328	CREB3;TRAF3;MAPK3
Citrate cycle (TCA cycle)	1/30	0.5323761135569396	0.9059217843952342	0	0	1.3333333333333333	0.8405400787509358	SUCLA2
Glyoxylate and dicarboxylate metabolism	1/30	0.5323761135569396	0.9009441921732824	0	0	1.3333333333333333	0.8405400787509358	AMT
Nicotinate and nicotinamide metabolism	1/30	0.5323761135569396	0.8960209998663246	0	0	1.3333333333333333	0.8405400787509358	PNP
p53 signaling pathway	2/72	0.5405975770602098	0.9049133355138296	0	0	1.111111111111111	0.6834223634393684	CCNB1;PERP
Circadian rhythm	1/31	0.5440842429149877	0.9058267395557633	0	0	1.2903225806451613	0.7853563687947012	NR1D1
beta-Alanine metabolism	1/31	0.5440842429149877	0.9009567033215925	0	0	1.2903225806451613	0.7853563687947012	CARNS1
Metabolism of xenobiotics by cytochrome P450	2/74	0.5554545611303542	0.9148663359794069	0	0	1.0810810810810811	0.635641590695438	EPHX1;CYP1B1
PPAR signaling pathway	2/74	0.5554545611303542	0.9100000256816442	0	0	1.0810810810810811	0.635641590695438	SLC27A2;PPARD
Propanoate metabolism	1/32	0.5554998006860319	0.9052589344513112	0	0	1.25	0.7348587858794243	SUCLA2
Pancreatic cancer	2/75	0.5627543403864517	0.9122544044159322	0	0	1.0666666666666667	0.6132395588377343	BAK1;MAPK3
Base excision repair	1/33	0.5666300836000462	0.9137280929257289	0	0	1.2121212121212122	0.6885437552033686	PCNA
Fructose and mannose metabolism	1/33	0.5666300836000462	0.9089690924417407	0	0	1.2121212121212122	0.6885437552033686	HK3
Chronic myeloid leukemia	2/76	0.5699678510175187	0.9095860005875428	0	0	1.0526315789473684	0.5917634962819259	BAK1;MAPK3
Endocytosis	6/244	0.5735012898731003	0.9105072024789429	0	0	0.9836065573770492	0.5468804196298948	SH3GLB2;ACAP1;AGAP2;WAS;ARRB1;VPS37A
Antigen processing and presentation	2/77	0.5770948361053473	0.9115138949766511	0	0	1.0389610389610389	0.571167444479923	CD4;CTSL
Cardiac muscle contraction	2/78	0.5841351052931448	0.9179265940320847	0	0	1.0256410256410255	0.5514081827999194	CACNA2D3;SLC8A1
Synaptic vesicle cycle	2/78	0.5841351052931448	0.9132670681740538	0	0	1.0256410256410255	0.5514081827999194	ATP6V1D;ATP6V0A1
Hepatitis B	4/163	0.5844865947758509	0.9092013696513236	0	0	0.9815950920245399	0.5271376027958177	CREB3;PCNA;TRAF3;MAPK3
RNA degradation	2/79	0.591088531821221	0.9148505919645028	0	0	1.0126582278481011	0.5324450357053537	C1D;EXOSC3
Cytokine-cytokine receptor interaction	7/294	0.60484112466593	0.9314553319855322	0	0	0.9523809523809523	0.47884710409113646	CD4;CSF3R;TNFSF14;CCL7;TNFSF12;IL36RN;CXCR6
African trypanosomiasis	1/37	0.6084381377362886	0.9323330667799846	0	0	1.0810810810810811	0.5371459840670496	PLCB2
Aldosterone-regulated sodium reabsorption	1/37	0.6084381377362886	0.9277175565484005	0	0	1.0810810810810811	0.5371459840670496	MAPK3
Taste transduction	2/83	0.6180333278447322	0.9377057387989041	0	0	0.963855421686747	0.4638196572792209	PRKACA;PLCB2
Regulation of actin cytoskeleton	5/214	0.6225776886263119	0.9399702357691376	0	0	0.9345794392523363	0.44288491348051257	FGF18;WAS;ITGB8;ITGAV;MAPK3
ErbB signaling pathway	2/85	0.6309855429295065	0.9480173035233561	0	0	0.9411764705882353	0.433385720533733	PLCG1;MAPK3
Colorectal cancer	2/86	0.6373322377682995	0.95290451083804	0	0	0.9302325581395349	0.4190364586262058	BAK1;MAPK3
Salmonella infection	2/86	0.6373322377682995	0.9483011074040398	0	0	0.9302325581395349	0.4190364586262058	WAS;MAPK3
Homologous recombination	1/41	0.6462201541186453	0.9569029205218401	0	0	0.975609756097561	0.42596589015410175	RPA3
Spliceosome	3/134	0.6547658919846503	0.9649181566089584	0	0	0.8955223880597014	0.37923360362939756	SNRNP40;U2AF2;USP39
Porphyrin and chlorophyll metabolism	1/42	0.6550827855909762	0.9607880855334318	0	0	0.9523809523809523	0.4028511058268805	CPOX
Tryptophan metabolism	1/42	0.6550827855909762	0.9562345874977283	0	0	0.9523809523809523	0.4028511058268805	CYP1B1
Protein digestion and absorption	2/90	0.6618632480006403	0.9615749074726284	0	0	0.8888888888888888	0.3668411719125685	KCNQ1;SLC8A1
mRNA surveillance pathway	2/91	0.6677839316144591	0.9656218353861663	0	0	0.8791208791208791	0.3549807590642075	PPP2CB;PELO
Measles	3/138	0.6742132929355205	0.970363057122151	0	0	0.8695652173913043	0.3427902258877473	TRAF3;CSNK2A2;BAK1
Herpes simplex virus 1 infection	11/492	0.6891632159725742	0.9872663745095481	0	0	0.8943089430894309	0.33293078260149234	ZNF584;EIF2B2;TNFSF14;TRAF3;ZSCAN32;CARD9;ZNF416;ZNF768;ZNF316;BAK1;ZNF200
Parkinson disease	3/142	0.6928430087684716	0.9879428087994873	0	0	0.8450704225352113	0.3101001498841745	LRRK2;VDAC1;PRKACA
Ether lipid metabolism	1/47	0.69618066242957	0.9881273918355187	0	0	0.8510638297872339	0.30820942968045956	PLD4
Prostate cancer	2/97	0.7015629289067601	0.9911990004737711	0	0	0.8247422680412371	0.29232550701224613	CREB3;MAPK3
Amino sugar and nucleotide sugar metabolism	1/48	0.7037940023867141	0.9898107430826846	0	0	0.8333333333333333	0.29272464657414204	HK3
Notch signaling pathway	1/48	0.7037940023867141	0.9853116033413997	0	0	0.8333333333333333	0.29272464657414204	DTX3
Mineral absorption	1/51	0.7255104548045064	1.0	0	0	0.7843137254901961	0.25167042845488546	SLC8A1
mTOR signaling pathway	3/152	0.7358789564635041	1.0	0	0	0.7894736842105262	0.24212339613573824	WNT10B;ATP6V1D;MAPK3
C-type lectin receptor signaling pathway	2/104	0.737315155331438	1.0	0	0	0.7692307692307693	0.23441527617042462	CARD9;MAPK3
Glycosaminoglycan biosynthesis	1/53	0.7390978494043314	1.0	0	0	0.7547169811320754	0.22816978033568033	UST
Epstein-Barr virus infection	4/201	0.7434367888046584	1.0	0	0	0.7960199004975124	0.2359972418836174	TRAF3;BTK;CD58;BAK1
Fanconi anemia pathway	1/54	0.7456376971972923	1.0	0	0	0.7407407407407407	0.21741885729120122	RPA3
Legionellosis	1/55	0.752013933732217	1.0	0	0	0.7272727272727272	0.20727303731253116	CR1
Pyrimidine metabolism	1/57	0.7642918118808011	1.0	0	0	0.7017543859649122	0.18863551580170362	PNP
Cellular senescence	3/160	0.7667655416368673	1.0	0	0	0.7499999999999999	0.1991806550221081	CCNB1;VDAC1;MAPK3
Leukocyte transendothelial migration	2/112	0.7736407907197486	1.0	0	0	0.7142857142857142	0.1833197198535737	NCF1;PLCG1
Lysine degradation	1/59	0.7759629585959883	1.0	0	0	0.6779661016949152	0.1719664364110286	KMT2D
Toxoplasmosis	2/113	0.7778595415712045	1.0	0	0	0.7079646017699115	0.17784729835672625	LAMA5;MAPK3
cAMP signaling pathway	4/212	0.7796958874359609	1.0	0	0	0.7547169811320754	0.18781231941672752	CREB3;ADCY3;PRKACA;MAPK3
Steroid hormone biosynthesis	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	CYP1B1
Cytosolic DNA-sensing pathway	1/63	0.7976032864598676	1.0	0	0	0.6349206349206349	0.143583453909114	POLR3C
Neurotrophin signaling pathway	2/119	0.8017528596829252	1.0	0	0	0.6722689075630252	0.14854109150517988	PLCG1;MAPK3
Alzheimer disease	3/171	0.8043668655403171	1.0	0	0	0.7017543859649122	0.15277179891457604	LRP1;PLCB2;MAPK3
AMPK signaling pathway	2/120	0.8055060782966527	1.0	0	0	0.6666666666666666	0.1441896869343059	CREB3;PPP2CB
Retinol metabolism	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	RDH10
Staphylococcus aureus infection	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	FCGR2C
Prolactin signaling pathway	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	MAPK3
RIG-I-like receptor signaling pathway	1/70	0.8305746692313859	1.0	0	0	0.5714285714285714	0.10607854011592341	TRAF3
Natural killer cell mediated cytotoxicity	2/131	0.842793086389536	1.0	0	0	0.6106870229007633	0.10444812227821715	PLCG1;MAPK3
Oxidative phosphorylation	2/133	0.8488334569866297	1.0	0	0	0.6015037593984962	0.09858181994056327	ATP6V1D;ATP6V0A1
Neuroactive ligand-receptor interaction	6/338	0.8521740601515955	1.0	0	0	0.7100591715976331	0.11358424407040531	VIPR1;NMB;THRA;P2RX1;S1PR1;NMUR1
Pertussis	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	MAPK3
Protein processing in endoplasmic reticulum	2/165	0.9206162754068306	1.0	0	0	0.4848484848484848	0.040102772666927876	GANAB;BAK1
Influenza A	2/171	0.929868102034189	1.0	0	0	0.4678362573099415	0.03401755726912288	VDAC1;MAPK3
Drug metabolism	1/108	0.9355414383081698	1.0	0	0	0.37037037037037035	0.02467771810747774	FMO5
MicroRNAs in cancer	4/299	0.9433763404609408	1.0	0	0	0.5351170568561873	0.03119196653246617	CYP1B1;PLCG1;BAK1;MET
Transcriptional misregulation in cancer	2/186	0.9487398715622468	1.0	0	0	0.43010752688172044	0.022632527264299238	BAK1;MET
Ubiquitin mediated proteolysis	1/137	0.9692072533500224	1.0	0	0	0.291970802919708	0.009131914223382517	CDC26
JAK-STAT signaling pathway	1/162	0.9837256304401564	1.0	0	0	0.24691358024691357	0.0040514201639341345	CSF3R
Necroptosis	1/162	0.9837256304401564	1.0	0	0	0.24691358024691357	0.0040514201639341345	VDAC1
Olfactory transduction	5/444	0.9874337067649512	1.0	0	0	0.4504504504504504	0.005696358941559757	SLC24A4;ADCY3;ARRB1;PRKACA;SLC8A1
